top Strip
 
Skip navigation links
Translation
Media enquiries
Your Information
Your Website
iwantgreatcare.org
Open and Honest Care
Britain's Greenest Hospital
Cookie Policy
Contact Us




UHSM leads the UK in clinical trial recruitment

“This is a remarkable achievement by UHSM’s staff. As a Trust, we have worked hard to increase the opportunities for patients to take part in research, and this effort has clearly been extraordinarily effective. I am enormously proud of the contribution our hospital is now making to the future of treatments in the UK.”

Julian Hartley
Chief Executive

UHSM is proud to be leading the UK when it comes to recruiting patients for clinical research trials.

Highlighted in a league table published by the National Institute for Health Research (NIHR) Clinical Research Network, the Trust recruited 20,612 patients in 2011/12 - the highest total for an NHS Trust.

One of the main reasons for our success our groundbreaking PROCAS trial, taking place at our Nightingale Centre & Genesis Prevention Centre, which aims to predict breast cancer risk for women who attend routine NHS breast screening in Greater Manchester. It has recently reached the 40,000 participant mark, from its ultimate target of 60,000.

Clinical trials are an important step in discovering new treatments for breast cancer and other diseases as well as new ways to detect, diagnose, and reduce the risk of disease. Clinical trials show researchers what does and doesn’t work in people. Clinical trials also help researchers and doctors decide if the side effects of a new treatment are acceptable when weighed against the benefits offered by the new treatment.

Fostering a research-active culture brings a host of benefits for patients, clinicians and the NHS. It drives innovation, gives rise to better and more cost-effective treatments, and creates opportunities for staff development. Growing evidence also suggests that NHS organisations that are research-active appear to do better in overall performance, and an organisation’s research activity is linked to improved patient outcomes.

Praising the achievement of UHSM, Dr Jonathan Sheffield, Chief Executive of the NIHR Clinical Research Network, said: “This is fantastic news and illustrates that our partners at UHSM are truly placing research at the core of NHS business. Their recruitment indicates a strong commitment to research and innovation as well as their drive to improve clinical outcomes for patients. We are keen to see other Trusts follow their example and truly embed research as a standard option within their care culture.”

To view the league table in full, click here. To find out more about clinical trials at UHSM, click here.

News headlinesNews headlines

UHSM secures £2.5 million funding for clinical research

Government awards UHSM money to research diseases and illnesses that affect Manchester's population.

Royle Welcome for UK’s first Siemens Aera MRI Scanner

Caroline Aherne opens UHSM's brand new Magnetic Resonance scanner.




 
Bottom Strip